Angiosarcoma and Haemoglobin decreased

Summary:

Haemoglobin decreased is found among people with Angiosarcoma, especially for people who are female, 60+ old.

The study analyzes which people have Haemoglobin decreased with Angiosarcoma. It is created by eHealthMe based on reports of 13 people who have Angiosarcoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Angiosarcoma?

Angiosarcoma (cancer of endothelial-type cells that line vessel walls) is found to be associated with 44 drugs and 149 conditions by eHealthMe. Check the latest studies of Angiosarcoma.

What is Haemoglobin decreased?

Haemoglobin decreased is found to be associated with 2,406 drugs and 3,133 conditions by eHealthMe. Check the latest studies of Haemoglobin decreased.



On Jul, 27, 2026

13 people who have Angiosarcoma and Haemoglobin Decreased are studied.

Would you have Haemoglobin decreased when you have Angiosarcoma?

Gender of people who have Angiosarcoma and experienced Haemoglobin Decreased *:

  • female: 63.64 %
  • male: 36.36 %

Age of people who have Angiosarcoma and experienced Haemoglobin Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 10 %
  • 50-59: 40 %
  • 60+: 50 %

Common co-existing conditions for these people *:

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 15.38%
  2. Stress And Anxiety: 1 person, 7.69%
  3. Angiosarcoma Metastatic (cancer of endothelial-type cells that line vessel walls-metastatic): 1 person, 7.69%
  4. Blood Pressure Abnormal: 1 person, 7.69%
  5. Cardiac Disorder: 1 person, 7.69%
  6. Cardiac Murmur (an heart sound in valve abnormality): 1 person, 7.69%
  7. Constipation: 1 person, 7.69%
  8. Depression: 1 person, 7.69%
  9. Gastritis - Chronic (long lasting inflammation of stomach): 1 person, 7.69%
  10. Gout (uric acid crystals building up in the body): 1 person, 7.69%

Common drugs taken by these people *:

  1. Nexium: 3 people, 23.08%
  2. Votrient: 3 people, 23.08%
  3. Yondelis: 2 people, 15.38%
  4. Avastin: 2 people, 15.38%
  5. Taxol: 2 people, 15.38%
  6. Opdivo: 2 people, 15.38%
  7. Gemcitabine: 2 people, 15.38%
  8. Intron A: 1 person, 7.69%
  9. Avapro: 1 person, 7.69%
  10. Cisplatin: 1 person, 7.69%

Common symptoms for these people *:

  1. Dyspnea (difficult or laboured breathing): 6 people, 46.15%
  2. Thrombocytopenia (decrease of platelets in blood): 5 people, 38.46%
  3. Aspartate Aminotransferase Increased: 4 people, 30.77%
  4. Alanine Aminotransferase Increased: 3 people, 23.08%
  5. Nausea (feeling of having an urge to vomit): 3 people, 23.08%
  6. Angiosarcoma Metastatic (cancer of endothelial-type cells that line vessel walls-metastatic): 3 people, 23.08%
  7. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 23.08%
  8. Gamma-Glutamyltransferase Increased: 2 people, 15.38%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 15.38%
  10. Haemorrhage (bleeding): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Haemoglobin decreased?

- Check whether Haemoglobin decreased is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Haemoglobin decreased:

All the conditions that are associated with Haemoglobin decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Haemoglobin decreased and Angiosarcoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: